Reasons for canakinumab initiation among patients with periodic fever syndromes: a retrospective medical chart review from the United States

BACKGROUND: Although canakinumab has demonstrated efficacy in multiple trials in patients with periodic fever syndromes (PFS), the evidence on initiation of canakinumab among PFS patients in real world setting is not well understood. We aimed to characterize the reasons for canakinumab initiation am...

Descripción completa

Detalles Bibliográficos
Autores principales: Hur, Peter, Lomax, Kathleen G., Ionescu-Ittu, Raluca, Manceur, Ameur M., Xie, Jipan, Cammarota, Jordan, Gautam, Raju, Sanghera, Navneet, Kim, Nina, Grom, Alexei A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439059/
https://www.ncbi.nlm.nih.gov/pubmed/34521444
http://dx.doi.org/10.1186/s12969-021-00605-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439059/
https://www.ncbi.nlm.nih.gov/pubmed/34521444
http://dx.doi.org/10.1186/s12969-021-00605-2

Ejemplares similares